110 Pages Pharma
Available Formats
ICRWorld’s Opioid-Induced Constipation market research report provides the newest industry data and industry future trends, allowing you to identify the products and end users driving Revenue growth and profitability.
The industry report lists the leading competitors and provides the insights strategic industry Analysis of the key factors influencing the market.
The report includes the forecasts, Analysis and discussion of important industry trends, market size, market share estimates and profiles of the leading industry Players.
Global Opioid-Induced Constipation Market: Product Segment Analysis
Methylnaltrexone Bromide
Lubiprostone
Naloxegol
Global Opioid-Induced Constipation Market: Application Segment Analysis
Hospital
Pharmacy
Global Opioid-Induced Constipation Market: Regional Segment Analysis
USA
Europe
Japan
China
India
South East Asia
The Players mentioned in our report
Takeda Pharmaceuticals
Bayer
Mallinckrodt
Salix (Bausch Health)
AstraZeneca
Progenics Pharmaceuticals
Purdue Pharm
Nektar Therapeutics
Daiichi Sankyo
Sanofi
Prestige
GSK
Shionogi
If you have any special requirements, please let us know and we will offer you the report as you want.
Chapter 1 About the Opioid-Induced Constipation Industry
1.1 Industry Definition and Types
1.1.1 Methylnaltrexone Bromide
1.1.2 Lubiprostone
1.1.3 Naloxegol
1.2 Main Market Activities
1.3 Similar Industries
1.4 Industry at a Glance
Chapter 2 World Market Competition Landscape
2.1 Opioid-Induced Constipation Markets by Regions
2.1.1 USA
Market Revenue (M USD) and Growth Rate 2014-2019
Sales and Growth Rate 2014-2019
Major Players
2.1.2 Europe
Market Revenue (M USD) and Growth Rate 2014-2019
Sales and Growth Rate 2014-2019
Major Players
2.1.3 China
Market Revenue (M USD) and Growth Rate 2014-2019
Sales and Growth Rate 2014-2019
Major Players
2.1.4 India
Market Revenue (M USD) and Growth Rate 2014-2019
Sales and Growth Rate 2014-2019
Major Players
2.1.5 Japan
Market Revenue (M USD) and Growth Rate 2014-2019
Sales and Growth Rate 2014-2019
Major Players
2.1.6 South East Asia
Market Revenue (M USD) and Growth Rate 2014-2019
Sales and Growth Rate 2014-2019
Major Players
2.2 World Opioid-Induced Constipation Market by Types
Methylnaltrexone Bromide
Lubiprostone
Naloxegol
2.3 World Opioid-Induced Constipation Market by Applications
Hospital
Pharmacy
2.4 World Opioid-Induced Constipation Market Analysis
2.4.1 World Opioid-Induced Constipation Market Revenue and Growth Rate 2014-2019
2.4.2 World Opioid-Induced Constipation Market Consumption and Growth rate 2014-2019
2.4.3 World Opioid-Induced Constipation Market Price Analysis 2014-2019
Chapter 3 World Opioid-Induced Constipation Market share
3.1 Major Production Market share by Players
3.2 Major Revenue (M USD) Market share by Players
3.3 Major Production Market share by Regions in 2019, Through 2024
3.4 Major Revenue (M USD) Market share By Regions in 2019, Through 2024
Chapter 4 Supply Chain Analysis
4.1 Industry Supply chain Analysis
4.2 Raw material Market Analysis
4.2.1 Raw material Prices Analysis 2014-2019
4.2.2 Raw material Supply Market Analysis
4.2 Manufacturing Equipment Suppliers Analysis
4.3 Production Process Analysis
4.4 Production Cost Structure Benchmarks
4.5 End users Market Analysis
Chapter 5 Company Profiles
5.1 Takeda Pharmaceuticals
5.1.1 Company Details (Foundation Year, Employee Strength and etc)
5.1.2 Product Information (Picture, Specifications and Applications)
5.1.3 Revenue (M USD), Price and Operating Profits
5.2 Bayer
5.2.1 Company Details (Foundation Year, Employee Strength and etc)
5.2.2 Product Information (Picture, Specifications and Applications)
5.2.3 Revenue (M USD), Price and Operating Profits
5.3 Mallinckrodt
5.3.1 Company Details (Foundation Year, Employee Strength and etc)
5.3.2 Product Information (Picture, Specifications and Applications)
5.3.3 Revenue (M USD), Price and Operating Profits
5.4 Salix (Bausch Health)
5.4.1 Company Details (Foundation Year, Employee Strength and etc)
5.4.2 Product Information (Picture, Specifications and Applications)
5.4.3 Revenue (M USD), Price and Operating Profits
5.5 AstraZeneca
5.5.1 Company Details (Foundation Year, Employee Strength and etc)
5.5.2 Product Information (Picture, Specifications and Applications)
5.5.3 Revenue (M USD), Price and Operating Profits
5.6 Progenics Pharmaceuticals
5.6.1 Company Details (Foundation Year, Employee Strength and etc)
5.6.2 Product Information (Picture, Specifications and Applications)
5.6.3 Revenue (M USD), Price and Operating Profits
5.7 Purdue Pharm
5.7.1 Company Details (Foundation Year, Employee Strength and etc)
5.7.2 Product Information (Picture, Specifications and Applications)
5.7.3 Revenue (M USD), Price and Operating Profits
5.8 Nektar Therapeutics
5.8.1 Company Details (Foundation Year, Employee Strength and etc)
5.8.2 Product Information (Picture, Specifications and Applications)
5.8.3 Revenue (M USD), Price and Operating Profits
5.9 Daiichi Sankyo
5.9.1 Company Details (Foundation Year, Employee Strength and etc)
5.9.2 Product Information (Picture, Specifications and Applications)
5.9.3 Revenue (M USD), Price and Operating Profits
5.10 Sanofi
5.10.1 Company Details (Foundation Year, Employee Strength and etc)
5.10.2 Product Information (Picture, Specifications and Applications)
5.10.3 Revenue (M USD), Price and Operating Profits
5.11 Prestige
5.11.1 Company Details (Foundation Year, Employee Strength and etc)
5.11.2 Product Information (Picture, Specifications and Applications)
5.11.3 Revenue (M USD), Price and Operating Profits
5.12 GSK
5.12.1 Company Details (Foundation Year, Employee Strength and etc)
5.12.2 Product Information (Picture, Specifications and Applications)
5.12.3 Revenue (M USD), Price and Operating Profits
5.13 Shionogi
5.13.1 Company Details (Foundation Year, Employee Strength and etc)
5.13.2 Product Information (Picture, Specifications and Applications)
5.13.3 Revenue (M USD), Price and Operating Profits
Chapter 6 Globalisation & Trade
6.1 Business Locations
6.2 Supply channels
6.3 Marketing strategy
6.4 Barriers to Entry
Chapter 7 Distributors and Customers
7.1 Major Distributors and contact information by Regions
7.2 Major Customers and contact information by Regions
Chapter 8 Import, Export, Consumption and Consumption Value by Major Countries
8.1 USA
8.2 Germany
8.3 China
8.4 Japan
8.5 India
Chapter 9 World Opioid-Induced Constipation Market Forecast through 2024
9.1 World Opioid-Induced Constipation Demand by Regions Forecast through 2024
9.2 World Opioid-Induced Constipation Price(by Regions, Types, Applications)Analysis Forecast through 2024
9.3 World Opioid-Induced Constipation Revenue (M USD)(by Regions, Types, Applications) Forecast through 2024
9.4 World Opioid-Induced Constipation Market Analysis
9.4.1 World Opioid-Induced Constipation Market Revenue and Growth Rate 2014-2019
9.4.2 World Opioid-Induced Constipation Market Consumption and Growth rate 2014-2019
9.4.3 World Opioid-Induced Constipation Market Price Analysis 2014-2019
Chapter 10 Key success factors and Market Overview
If you have any special requirements, please let us know and we will offer you the report as you want.
Table Main Market Activities by Regions
Table Market Revenue (M USD) and Growth Rate 2014-2019
Table Major Players
Table Market Revenue (M USD) and Growth Rate 2014-2019
Table Major Players
Table Market Revenue (M USD) and Growth Rate 2014-2019
Table Major Players
Table Market Revenue (M USD) and Growth Rate 2014-2019
Table Major Players
Table Market Revenue (M USD) and Growth Rate 2014-2019
Table Major Players
Table Major Production Market share by Players 2018
Table Major Revenue (M USD) Market share by Players 2018
Table Production Market share by Major Regions in 2014-2019
Table Production Market share by Major Regions in 2019-2024
Table Revenue (M USD) Market share by Regions in 2014-2019
Table Revenue (M USD) Market share by Regions in 2019-2024
Table Industry Supply chain Analysis
Table Raw material Prices Analysis 2014-2019
Table Raw material Suppliers Market Analysis
Table Manufacturing Equipment Suppliers Analysis
Figure Production Process Analysis
Figure Production Cost Structure
Table major End Users by Regions
Table Takeda Pharmaceuticals Information List
Figure Opioid-Induced ConstipationOpioid-Induced Constipation Picture, Specifications and Applications of Takeda Pharmaceuticals
Table Opioid-Induced Constipation Sales Volume, Price, Operating Cost, Operating Profits, Revenue (M USD) and Profits Margin of Takeda Pharmaceuticals 2018-2019
Figure Opioid-Induced Constipation Sales Volume and World Market Share of Takeda Pharmaceuticals 2018-2019
Table Bayer Information List
Figure Opioid-Induced Constipation Picture, Specifications and Applications of Bayer
Table Opioid-Induced Constipation Sales Volume, Price, Operating Cost, Operating Profits, Revenue (M USD) and Profits Margin of Bayer 2018-2019
Figure Opioid-Induced Constipation Sales Volume and World Market Share of Bayer 2018-2019
Table Mallinckrodt Information List
Figure Opioid-Induced Constipation Picture, Specifications and Applications of Mallinckrodt
Table Opioid-Induced Constipation Sales Volume, Price, Operating Cost, Operating Profits, Revenue (M USD) and Profits Margin of Mallinckrodt 2018-2019
Figure Opioid-Induced Constipation Sales Volume and World Market Share of Mallinckrodt 2018-2019
Table Salix (Bausch Health) Information List
Figure Opioid-Induced Constipation Picture, Specifications and Applications of Salix (Bausch Health)
Table Opioid-Induced Constipation Sales Volume, Price, Operating Cost, Operating Profits, Revenue (M USD) and Profits Margin of Salix (Bausch Health) 2018-2019
Figure Opioid-Induced Constipation Sales Volume and World Market Share of Salix (Bausch Health) 2018-2019
Table AstraZeneca Information List
Figure Opioid-Induced Constipation Picture, Specifications and Applications of AstraZeneca
Table Opioid-Induced Constipation Sales Volume, Price, Operating Cost, Operating Profits, Revenue (M USD) and Profits Margin of AstraZeneca 2018-2019
Figure Opioid-Induced Constipation Sales Volume and World Market Share of AstraZeneca 2018-2019
Table Progenics Pharmaceuticals Information List
Figure Opioid-Induced Constipation Picture, Specifications and Applications of Progenics Pharmaceuticals
Table Opioid-Induced Constipation Sales Volume, Price, Operating Cost, Operating Profits, Revenue (M USD) and Profits Margin of Progenics Pharmaceuticals 2018-2019
Figure Opioid-Induced Constipation Sales Volume and World Market Share of Progenics Pharmaceuticals 2018-2019
Table Purdue Pharm Information List
Figure Opioid-Induced Constipation Picture, Specifications and Applications of Purdue Pharm
Table Opioid-Induced Constipation Sales Volume, Price, Operating Cost, Operating Profits, Revenue (M USD) and Profits Margin of Purdue Pharm 2018-2019
Figure Opioid-Induced Constipation Sales Volume and World Market Share of Purdue Pharm 2018-2019
Table Nektar Therapeutics Information List
Figure Opioid-Induced Constipation Picture, Specifications and Applications of Nektar Therapeutics
Table Opioid-Induced Constipation Sales Volume, Price, Operating Cost, Operating Profits, Revenue (M USD) and Profits Margin of Nektar Therapeutics 2018-2019
Figure Opioid-Induced Constipation Sales Volume and World Market Share of Nektar Therapeutics 2018-2019
Table Daiichi Sankyo Information List
Figure Opioid-Induced Constipation Picture, Specifications and Applications of Daiichi Sankyo
Table Opioid-Induced Constipation Sales Volume, Price, Operating Cost, Operating Profits, Revenue (M USD) and Profits Margin of Daiichi Sankyo 2018-2019
Figure Opioid-Induced Constipation Sales Volume and World Market Share of Daiichi Sankyo 2018-2019
Table Sanofi Information List
Figure Opioid-Induced Constipation Picture, Specifications and Applications of Sanofi
Table Opioid-Induced Constipation Sales Volume, Price, Operating Cost, Operating Profits, Revenue (M USD) and Profits Margin of Sanofi 2018-2019
Figure Opioid-Induced Constipation Sales Volume and World Market Share of Sanofi 2018-2019
Table Prestige Information List
Figure Opioid-Induced Constipation Picture, Specifications and Applications of Prestige
Table Opioid-Induced Constipation Sales Volume, Price, Operating Cost, Operating Profits, Revenue (M USD) and Profits Margin of Prestige 2018-2019
Figure Opioid-Induced Constipation Sales Volume and World Market Share of Prestige 2018-2019
Table GSK Information List
Figure Opioid-Induced Constipation Picture, Specifications and Applications of GSK
Table Opioid-Induced Constipation Sales Volume, Price, Operating Cost, Operating Profits, Revenue (M USD) and Profits Margin of GSK 2018-2019
Figure Opioid-Induced Constipation Sales Volume and World Market Share of GSK 2018-2019
Table Shionogi Information List
Figure Opioid-Induced Constipation Picture, Specifications and Applications of Shionogi
Table Opioid-Induced Constipation Sales Volume, Price, Operating Cost, Operating Profits, Revenue (M USD) and Profits Margin of Shionogi 2018-2019
Figure Opioid-Induced Constipation Sales Volume and World Market Share of Shionogi 2018-2019
Table Business Locations
Figure Supply channels
Figure Marketing strategy
Table Barriers Analysis to Entry
Table Major Distributors and contact information by Regions
Table Major Customers and contact information by Regions
Table USA Supply, Import, Export, Consumption and Consumption Value(M USD)
Table Germany Supply, Import, Export, Consumption and Consumption Value(M USD)
Table China Supply, Import, Export, Consumption and Consumption Value(M USD)
Table Japan Supply, Import, Export, Consumption and Consumption Value(M USD)
Table India Supply, Import, Export, Consumption and Consumption Value(M USD)
Table World Demand by Regions Forecast Analysis of Opioid-Induced Constipation (2019-2024)
Table World Price by Regions Forecast Analysis of Opioid-Induced Constipation (2019-2024)
Table World Price by Types Forecast Analysis of Opioid-Induced Constipation (2019-2024)
Table World Price by Applications Forecast Analysis of Opioid-Induced Constipation (2019-2024)
Table World Revenue (M USD) by Regions Forecast Analysis of Opioid-Induced Constipation (2019-2024)
Table World Revenue (M USD) by Types Forecast Analysis of Opioid-Induced Constipation (2019-2024)
Table World Revenue (M USD) by Applications Forecast Analysis of Opioid-Induced Constipation (2019-2024)
If you have any special requirements, please let us know and we will offer you the report as you want.
If you have any special requirements, please let us know and we will offer you the report as you want.